Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

Recruiting · NCT06796686 · Registry updated 2025-09-25

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health	Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Recruiting	Phase 1	2025-09-25		NCT06796686

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Institute of Allergy and Infectious Diseases (NIAID)	402

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Bridge HIV, San Francisco Department of Public Health	San Francisco	United States	4
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)	Boston	United States	2
Columbia Physicians & Surgeons	New York	United States	1
NY Blood Center CRS	New York	United States	1
Ponce de Leon Center CRS	Atlanta	United States	1
The Hope Clinic of the Emory Vaccine Research Center; Emory University	Decatur	United States	3